Clinical Trial Update: Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vadadustat for correction or maintenance treatment of anemia in incident dialysis-dependent CKD; study completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Dialysis-dependent Chronic Kidney Disease

Drugs mentioned

• Vadadustat (vadadustat)

Snippet

Sponsor: Akebia Therapeutics | Conditions: Anemia, Dialysis-Dependent Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-07-18